Showing 1 - 3 results of 3 for search '"early access program"', query time: 0.04s Refine Results
  1. 1
    Safety and efficacy of telaprevir in treatment of a chronic hepatitis C in patients of the Russian population included in early access program study

    Safety and efficacy of telaprevir in treatment of a chronic hepatitis C in patients of the Russian population included in early access program study by D. T. Abrurakhmanov, V. G. Morozov, I. G. Nikitin, P. O. Bogomolov, N. I. Geyvandova, Ye. N. Bessonova, I. G. Bakulin, V. A. Isakov, K. V. Zhdanov, M. V. Mayevskaya, Ye. A. Nurmukhametova, E. Z. Burnevich, Ye. V. Chesnokov, V. D. Pasechnikov, A. Hill, I. Lonjon-Domanec, S. N. Kizhlo

    Published 2014-07-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    The use of cannabidiol in patients with Lennox-Gastaut syndrome and Dravet syndrome in the UK Early Access Program: A retrospective chart review study

    The use of cannabidiol in patients with Lennox-Gastaut syndrome and Dravet syndrome in the UK Early Access Program: A retrospective chart review study by Christin Eltze, Shaikha Alshehhi, Aisha Al Ghfeli, Kishan Vyas, Seeta Saravanai-Prabu, Gaelle Gusto, Artak Khachatryan, Marta Martinez, Archana Desurkar

    Published 2025-03-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Treatment of resistant forms of systemic lupus erythematosus with a type I interferon inhibitor in the early access program

    Treatment of resistant forms of systemic lupus erythematosus with a type I interferon inhibitor in the early access program by I. A. Leineman, R. R. Samigullina, M. S. Shostak, V. I. Mazurov

    Published 2023-04-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: